Significant Ownership of Freebird Partners LP

Signature - Title
/s/ Curtis Huff - Curtis Huff, Chairman and President
Location
Houston, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Freebird Partners LP.

Notify me when Freebird Partners LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Freebird Partners LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ERNA Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share 9.9% $1,234,083 786,040 Freebird Partners LP 19 Dec 2025
ERNA Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share 9.9% $1,180,191 +$204,218 6,211,530 +21% Freebird Partners LP 31 Mar 2025

Schedules 13D/G Reported by Freebird Partners LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.